Based on this, this study integrated and designed an experiment that aimed to explore whether PPAR-γ could reduce inflammation and prevent gallstones by regulating the expression of NF-kB pathway and RAGE, to achieve the purpose of alleviating CGD, which is expected to provide potential targets and experimental evidence for the treatment of traditional Chinese medicine for CGD. The gene discussed is NFKB1; the disease is gallstones.